Key result
Severe COVID-19 links to shared vagal dysfunction, highlighting non-invasive vagus nerve stimulation as potential therapy.
Why the study?
COVID-19 mortality is disproportionately high in older populations and Alzheimer's disease is a major risk factor, prompting a review of how COVID-19 complications converge with autonomic dysfunctions in Alzheimer's disease and aging.
Design
Review
Authors
Loading...
Hypothesis-generating for nVNS in severe COVID-19 and Alzheimer's; prospective trials needed before clinical adoption.
The paper proposes that vagal autonomic dysfunction links severe COVID-19, aging, and Alzheimer's disease, highlighting non-invasive vagus nerve stimulation as a potential therapeutic approach.
Rangon et al. (2020) conducted a review in COVID-19, Alzheimer's Disease, Aging. Vagus nerve stimulation was evaluated. Severe COVID-19 outcomes may rely on vagal autonomic dysfunction shared with Alzheimer's disease and aging, highlighting non-invasive vagus nerve stimulation as a potential therapeutic approach.